BioNexus Gene Lab Corp. (BGLC)
OTCMKTS: BGLC · Delayed Price · USD
0.600
+0.018 (3.11%)
Apr 24, 2024, 2:05 PM EDT - Market open

Company Description

BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn.

Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia.

Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments.

The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers.

The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

BioNexus Gene Lab Corp.
BioNexus Gene Lab logo
Country Malaysia
Founded 2017
Industry Specialty Chemicals
Sector Materials
Employees 27
CEO Su-Leng Tan

Contact Details

Address:
10-2 Tower B, Vertical Business Suite, 8 Jalan Kerinchi,
Kuala Lumpur, N8 59200
Malaysia
Phone 1-307-241-6898
Website bionexusgenelab.com

Stock Details

Ticker Symbol BGLC
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001737523
CUSIP Number 090628108
ISIN Number US0906282076
Employer ID 26-2124961
SIC Code 8071

Key Executives

Name Position
Su-Leng Tan Chief Executive Officer and Director
Kwan Wah Chan Marketing Manager
Too Kam Tham Managing Director

Latest SEC Filings

Date Type Title
Apr 18, 2024 8-K Current Report
Apr 16, 2024 10-K Annual Report
Apr 1, 2024 8-K Current Report
Mar 28, 2024 NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Mar 26, 2024 10-Q/A [Amend] Quarterly report
Feb 29, 2024 DEF 14C Filing
Jan 26, 2024 PRE 14C Filing
Jan 17, 2024 SC 13D General statement of acquisition of beneficial ownership
Nov 20, 2023 10-Q Quarterly Report
Nov 14, 2023 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB